North America Autotransfusion Devices Market Growth Opportunities and Forecast by 2028

The autotransfusion devices market in North America is expected to grow from US$ 328.30 million in 2021 to US$ 448.50 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.

Organ transplantation is a surgical procedure performed in case of organ failure. Usually, organ transplantation is conducted for organs such as the heart, liver, and kidney; however, with rising cases of chronic diseases, transplantation is needed for other organs such as lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the figure of "Donation Physicians" - intensive care doctors who are responsible for organ donation. The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in organ transplant surgeries. Countries are progressing in terms of providing better and advanced medical treatments. Thus, the rising need for organ transplantation is among the key factors driving the demand for transplant diagnostics, such as autotransfusion devices.

North America Autotransfusion Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Autotransfusion Devices Market Segmentation         

The North America autotransfusion devices market is segmented on the basis of type, application, end user, and country. The market, by type, is bifurcated into products and accessories. In 2021, the accessories segment held a larger market share. The market for the products segment is further segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest market share. The North America autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest market share in 2021. Based on end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Based on country, the market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2021. 

BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the North America autotransfusion devices market.

North America Autotransfusion Devices Report Scope